Cleared Traditional

K060423 - CYAN DXD, MULTITEST CD8/CD4/CD3, CD3-FITC, CD3-RPE, CD3-APC AND FLUOROSPHERES

K060423 is an FDA 510(k) clearance for CYAN DXD, manufactured by Dakocytomation California, Inc.. The device is a Class 2 Hematology device with product code GKZ cleared through the Traditional 510(k) pathway after a 179-day FDA review.

K060423 · Dakocytomation California, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2006
Decision
179d
Days
Class 2
Risk

K060423 is an FDA 510(k) clearance for the CYAN DXD, MULTITEST CD8/CD4/CD3, CD3-FITC, CD3-RPE, CD3-APC AND FLUOROSPHERES. Classified as Counter, Differential Cell (product code GKZ), Class II - Special Controls.

Submitted by Dakocytomation California, Inc. (Carpinteria, US). The FDA issued a Cleared decision on August 15, 2006 after a review of 179 days - an extended review cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5220 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Dakocytomation California, Inc. devices

FDA 510(k) Submission Details - K060423

510(k) Number K060423 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 17, 2006
Decision Date August 15, 2006
Days to Decision 179 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
66d slower than avg
Panel avg: 113d · This submission: 179d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GKZ Device Classification - Class 2, Special Controls

Product Code GKZ Counter, Differential Cell
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GKZ Counter, Differential Cell

All 296
Devices cleared under the same product code (GKZ) and FDA review panel - the closest regulatory comparables to K060423.
CYTOMICS FC 500 MPL FLOW CYTOMETER, MODEL # 626554
K071681 · Beckman Coulter, Inc. · Oct 2007
BC-3200 AUTO HEMATOLOGY ANALYZER
K063407 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Jun 2007
COULTER LH 780 HEMATOLOGY ANALYZER
K061616 · Beckman Coulter, Inc. · Oct 2006
COULTER LH 750 HEMATOLOGY ANALYZER, MODEL 6605632
K061574 · Beckman Coulter, Inc. · Jul 2006
CELL-DYN RUBY SYSTEM
K061667 · Abbott Laboratories · Jul 2006
SYSMEX AUTOMATED HEMATOLOGY ANALYZER, XT-SERIES
K061150 · Sysmex America, Inc. · Jul 2006